Cargando…

Assessing Clinical Outcomes in Colorectal Cancer with Assays for Invasive Circulating Tumor Cells

Colorectal carcinoma (CRC) is the second leading cause of cancer-related mortality. The goals of this study are to evaluate the association between levels of invasive circulating tumor cells (iCTCs) with CRC outcomes and to explore the molecular characteristics of iCTCs. Peripheral blood from 93 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yue, Zarrabi, Kevin, Hou, Wei, Madajewicz, Stefan, Choi, Minsig, Zucker, Stanley, Chen, Wen-Tien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027397/ https://www.ncbi.nlm.nih.gov/pubmed/29882767 http://dx.doi.org/10.3390/biomedicines6020069

Ejemplares similares

Multiregion Comprehensive Genomic Profiling of a Gastric Mixed Neuroendocrine-Nonneuroendocrine Neoplasm with Trilineage Differentiation
por: Farooq, Faheem, et al.
Publicado: (2018)

Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer
por: Tsai, Wen-Sy, et al.
Publicado: (2019)

Development of a High-Throughput Three-Dimensional Invasion Assay for Anti-Cancer Drug Discovery
por: Evensen, Nikki A., et al.
Publicado: (2013)

Detection of an ALK Fusion in Colorectal Carcinoma by Hybrid Capture‐Based Assay of Circulating Tumor DNA
por: Lai, Andrea Z., et al.
Publicado: (2017)

The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness
por: Dong, Huan, et al.
Publicado: (2019)

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
por: Myint, Ni Ni Moe, et al.
Publicado: (2018)

Plasma Seprase and DPP4 Levels as Markers of Disease and Prognosis in Cancer
por: Javidroozi, Mazyar, et al.
Publicado: (2012)

Binary-blend fibber-based capture assay of circulating tumor cells for clinical diagnosis of colorectal cancer
por: Lee, Ai-Wei, et al.
Publicado: (2018)

Circulating tumor cell assay to non-invasively evaluate PD-L1 and other therapeutic targets in multiple cancers
por: Page, Raymond, et al.
Publicado: (2022)

Clinical Utility of Positron Emission Tomography Magnetic Resonance Imaging (PET-MRI) in Gastrointestinal Cancers
por: Matthews, Robert, et al.
Publicado: (2016)

Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer
por: Boutin, Mélina, et al.
Publicado: (2023)

Early Assessment of Colorectal Cancer by Quantifying Circulating Tumor Cells in Peripheral Blood: ECT2 in Diagnosis of Colorectal Cancer
por: Chen, Chih-Jung, et al.
Publicado: (2017)

Application of Circulating Tumor DNA as a Non-Invasive Tool for Monitoring the Progression of Colorectal Cancer
por: Zhou, Jiaolin, et al.
Publicado: (2016)

Detection and clinical significance of circulating tumor cells in colorectal cancer
por: Jiang, Miao, et al.
Publicado: (2021)

Spotlight on liposomal irinotecan for metastatic pancreatic cancer: patient selection and perspectives
por: Woo, Wonhee, et al.
Publicado: (2019)

Development of a multiplex assay to assess activated p300/CBP in circulating prostate tumor cells
por: Filon, Mikolaj, et al.
Publicado: (2023)

Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer
por: Gong, Jun, et al.
Publicado: (2021)

Circulating tumor DNA correlates with microvascular invasion and predicts tumor recurrence of hepatocellular carcinoma
por: Wang, Jian, et al.
Publicado: (2020)

Detection of Molecular Residual Disease Using Personalized Circulating Tumor DNA Assay in Patients With Colorectal Cancer Undergoing Resection of Metastases
por: Loupakis, Fotios, et al.
Publicado: (2021)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Assessment of the Circulating Tumor Cells and Microsatellite Instability in Colorectal Cancer Patients: Prognostic and Diagnostic Value
por: Alsayed, Aya, et al.
Publicado: (2021)

Nab-paclitaxel: potential for the treatment of advanced pancreatic cancer
por: Al-Hajeili, Marwan, et al.
Publicado: (2014)

Clinical utility of circulating tumor DNA for colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2019)

Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells
por: Chen, Jie-Fu, et al.
Publicado: (2016)

Evaluation of circulating tumor cells in colorectal cancer using flow cytometry
por: Mușină, Ana-Maria, et al.
Publicado: (2021)

Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology
por: Deveson, Ira W., et al.
Publicado: (2021)

Clinical significance of circulating tumor cells in predicating the outcomes of patients with colorectal cancer
por: Chen, Kehe, et al.
Publicado: (2022)

Circulating Tumor DNA Dynamics and Treatment Outcome of Regorafenib in Metastatic Colorectal Cancer
por: Lee, Dae-Won, et al.
Publicado: (2023)

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients
por: Nguyen, Huu Thinh, et al.
Publicado: (2022)

Validation of a liquid biopsy assay with molecular and clinical profiling of circulating tumor DNA
por: Finkle, Justin D., et al.
Publicado: (2021)

Percutaneous Cryoablation of Metastatic Lesions from Colorectal Cancer: Efficacy and Feasibility with Survival and Cost-Effectiveness Observations
por: Bang, Hyun J., et al.
Publicado: (2012)

Circulating tumor cells participate in the formation of microvascular invasion and impact on clinical outcomes in hepatocellular carcinoma
por: Sun, Bin, et al.
Publicado: (2023)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021)

Liquid Biopsy for Prognosis and Treatment in Metastatic Colorectal Cancer: Circulating Tumor Cells vs Circulating Tumor DNA
por: Patelli, Giorgio, et al.
Publicado: (2021)

Blood free-circulating DNA testing by highly sensitive methylation assay to diagnose colorectal neoplasias
por: Suehiro, Yutaka, et al.
Publicado: (2018)

Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer
por: Osumi, Hiroki, et al.
Publicado: (2018)

Circulating and tumor-infiltrating Tim-3 in patients with colorectal cancer
por: Xu, Benling, et al.
Publicado: (2015)

Circulating cytokeratin-positive cells and tumor budding in colorectal cancer
por: Märkl, Bruno, et al.
Publicado: (2016)

Circulating Tumor Cells in Right- and Left-Sided Colorectal Cancer
por: Nicolazzo, Chiara, et al.
Publicado: (2019)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nc8p9k1s4a80tjgsfpqfeu9o9r